[Treatment of deep vein thrombosis with low molecular weight heparins at home].

Abstract

Treatment of patients with proximal vein thrombosis with low molecular weight heparins is effective and safe. So it allows "hospital at home" care. Among low molecular weight heparins tinzaparin is given once daily, making the compliance easier. The twenty patients with deep vein thrombosis who were assisted in the "hospital at home" unit of the Clínica Nuestra Señora de la Concepción in Madrid from December 1999 to December 2000. The mean of age was 71 + 15. The most frequent risk factors were surgery in past three months (19%), known tumour (15%) and previous venous thrombosis (15%). Eighteen patients were treated with tinzaparin. No patients showed adverse effects nor complications. Low molecular weight heparins, specially tinzaparin, are a safe and effective treatment for deep vein thrombosis in our unit.

• Authors: C G Suárez Alvarez, J García Cañete, M D Herrero Mendoza, T M Bellver Alvarez, R Arboiro Pinel
• Journal: Anales de medicina interna (Madrid, Spain : 1984) (An Med Interna) Vol. 20 Issue 3 Pg. 134-6 (Mar 2003) ISSN: 0212-7199 [Print] Spain
• Vernacular Title: Tratamiento en domicilio de trombosis venosa profunda con heparinas de bajo peso molecular. Experiencia de un año.
• PMID: 12756898 (Publication Type: Journal Article)

Chemical References

• Fibrinolytic Agents
• Heparin, Low-Molecular-Weight
• Tinzaparin

Topics

• Adult
• Aged
• Aged, 80 and over
• Ambulatory Care (methods)
• Female
• Fibrinolytic Agents (therapeutic use)
• Heparin, Low-Molecular-Weight (therapeutic use)
• Home Care Services, Hospital-Based
• Humans
• Male
• Middle Aged
• Risk Factors
• Tinzaparin
• Treatment Outcome
• Venous Thrombosis (drug therapy)